Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-07-037523
Filing Date
2007-05-09
Accepted
2007-05-09 15:54:42
Documents
5
Period of Report
2007-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a07-10961_110q.htm 10-Q 421101
2 EX-31.1 a07-10961_1ex31d1.htm EX-31.1 9635
3 EX-31.2 a07-10961_1ex31d2.htm EX-31.2 9632
4 EX-32.1 a07-10961_1ex32d1.htm EX-32.1 5785
5 EX-32.2 a07-10961_1ex32d2.htm EX-32.2 5793
  Complete submission text file 0001104659-07-037523.txt   453372
Mailing Address 22026 20TH AVENUE SE, SUITE 102 BOTHELL WA 98021
Business Address 22026 2OTH AVE SE STE 102 BOTHELL WA 98021 2064879500
SONUS PHARMACEUTICALS INC (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21243 | Film No.: 07832438
SIC: 2835 In Vitro & In Vivo Diagnostic Substances